Tenax Therapeutics, Inc.
TENX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000034956
In the last 90 days, Tenax Therapeutics, Inc. insiders filed 6 open-market purchases and 0 sales; 111 institutions reported holding it in 13F filings for Q2 2026, worth $441.4M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Tenax Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 9
- −8 vs. Q4 2023
- Shares held
- 7.24K
- −1.34M (−99.5%) vs. Q4 2023
- Total value
- $30.5K
- −$337.0K (−91.7%) vs. Q4 2023
- New holders
- 3
- 1 more added
- Sold out
- 11
- 5 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TENX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $441.4M |
| Q1 2026 | 81 | $341.0M |
| Q4 2025 | 49 | $85.9M |
| Q3 2025 | 34 | $35.9M |
| Q2 2025 | 26 | $12.9M |
| Q1 2025 | 23 | $13.1M |
| Q4 2024 | 21 | $8.43M |
| Q3 2024 | 19 | $4.25M |
| Q2 2024 | 11 | $57.2K |
| Q1 2024 | 9 | $30.5K |
| Q4 2023 | 17 | $367.6K |
| Q3 2023 | 16 | $184.8K |
| Q2 2023 | 15 | $119.2K |
| Q1 2023 | 13 | $230.6K |
| Q4 2022 | 19 | $691.8K |
| Q3 2022 | 29 | $1.24M |
| Q2 2022 | 25 | $2.08M |
| Q1 2022 | 25 | $6.54M |
| Q4 2021 | 28 | $8.38M |
| Q3 2021 | 25 | $13.6M |
| Q2 2021 | 25 | $7.32M |
| Q1 2021 | 26 | $7.21M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Tenax Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Qube Research & Technologies Ltd | 4,407 | $18.7K | 0.00% | +3,907+781.4% | Added |
| UBS Group AG | 1,384 | $5.87K | 0.00% | +1,384 | New |
| Tower Research Capital LLC (TRC) | 537 | $2.28K | 0.00% | −4,021−88.2% | Reduced |
| CIBC Private Wealth Group, LLC | 343 | $1.31K | 0.00% | +343 | New |
| BlackRock Inc. | 300 | $1.27K | 0.00% | −23,622−98.7% | Reduced |
| Morgan Stanley | 260 | $1.10K | 0.00% | −20,417−98.7% | Reduced |
| Wells Fargo & Company | 2 | $8 | 0.00% | −182−98.9% | Reduced |
| Allworth Financial LP | 1 | $5 | 0.00% | +1 | New |
| Tucker Asset Management LLC | 1 | $4 | 0.00% | −1−50.0% | Reduced |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −340,167−100.0% | Sold out |
| CI Private Wealth, LLC | 0 | $0 | 0.00% | −190,959−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −186,046−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −148,118−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −142,371−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −95,067−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −76,171−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −50,556−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −42,524−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −20,765−100.0% | Sold out |
| Banque Cantonale Vaudoise | 0 | $0 | 0.00% | −50−100.0% | Sold out |